Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

The Role of the TGF-β Superfamily in Myocardial Infarction

Open access
Hanna, Anis, Frangogiannis, Nikolaos G. · 2019 · Frontiers in Cardiovascular Medicine

Abstract

The members of the transforming growth factor β (TGF-β) superfamily are essential regulators of cell differentiation, phenotype and function, and have been implicated in the pathogenesis of many diseases. Myocardial infarction is associated with induction of several members of the superfamily, including TGF-β1, TGF-β2, TGF-β3, bone morphogenetic protein (BMP)-2, BMP-4, BMP-10, growth differentiation factor (GDF)-8, GDF-11 and activin A. This manuscript reviews our current knowledge on the patterns and mechanisms of regulation and activation of TGF-β superfamily members in the infarcted heart, and discusses their cellular actions and downstream signaling mechanisms. In the infarcted heart, TGF-β isoforms modulate cardiomyocyte survival and hypertrophic responses, critically regulate immune cell function, activate fibroblasts, and stimulate a matrix-preserving program. BMP subfamily members have been suggested to exert both pro- and anti-inflammatory actions and may regulate fibrosis. Members of the GDF subfamily may also modulate survival and hypertrophy of cardiomyocytes and regulate inflammation. Important actions of TGF-β superfamily members may be mediated through activation of Smad-dependent or non-Smad pathways. The critical role of TGF-β signaling cascades in cardiac repair, remodeling, fibrosis, and regeneration may suggest attractive therapeutic targets for myocardial infarction patients. However, the pleiotropic, cell-specific, and context-dependent actions of TGF-β superfamily members pose major challenges in therapeutic translation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcvm.2019.00140

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 178

  1. Frangogiannis, 2015, Pathophysiology of myocardial infarction, Compr Physiol., 5, 1841, 10.1002/cphy.c150006 · DOI · Paper page
  2. Reimer, 1977, The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs, Circulation., 56, 786, 10.1161/01.CIR.56.5.786 · DOI · Paper page
  3. Frangogiannis, 2012, Regulation of the inflammatory response in cardiac repair, Circ Res., 110, 159, 10.1161/CIRCRESAHA.111.243162 · DOI · Paper page
  4. Frangogiannis, 2017, The role of transforming growth factor (TGF)-beta in the infarcted myocardium, J Thorac Dis., 9, S52, 10.21037/jtd.2016.11.19 · DOI
  5. Thompson, 1989, Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice, J Cell Biol., 108, 661, 10.1083/jcb.108.2.661 · DOI · Paper page
  6. Heine, 1987, Role of transforming growth factor-beta in the development of the mouse embryo, J Cell Biol., 105, 2861, 10.1083/jcb.105.6.2861 · DOI · Paper page
  7. Bartram, 2001, Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-β(2)-knockout mice, Circulation., 103, 2745, 10.1161/01.CIR.103.22.2745 · DOI · Paper page
  8. Umbarkar, 2019, Cardiomyocyte SMAD4-dependent TGF-β signaling is essential to maintain adult heart homeostasis, JACC Basic Transl Sci., 4, 41, 10.1016/j.jacbts.2018.10.003 · DOI
  9. Roberts, 1992, Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1, J Clin Invest., 90, 2056, 10.1172/JCI116087 · DOI
  10. Dewald, 2004, Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction, Am J Pathol., 164, 665, 10.1016/S0002-9440(10)63154-9 · DOI · Paper page
  11. Wunsch, 1991, In situ localization of transforming growth factor beta 1 in porcine heart: enhanced expression after chronic coronary artery constriction, J Mol Cell Cardiol., 23, 1051, 10.1016/0022-2828(91)91640-D · DOI
  12. Vilahur, 2011, Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction, J Mol Cell Cardiol., 50, 522, 10.1016/j.yjmcc.2010.12.021 · DOI · Paper page
  13. Hao, 1999, Elevation of expression of Smads 2, 3, and 4, decorin and TGF-β in the chronic phase of myocardial infarct scar healing, J Mol Cell Cardiol., 31, 667, 10.1006/jmcc.1998.0902 · DOI · Paper page
  14. Deten, 2001, Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats, J Mol Cell Cardiol., 33, 1191, 10.1006/jmcc.2001.1383 · DOI · Paper page
  15. Bujak, 2007, The role of TGF-β signaling in myocardial infarction and cardiac remodeling, Cardiovasc Res., 74, 184, 10.1016/j.cardiores.2006.10.002 · DOI · Paper page
  16. Dewald, 2005, CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts, Circ Res., 96, 881, 10.1161/01.RES.0000163017.13772.3a · DOI · Paper page
  17. Jia, 2019, Interleukin-35 promotes macrophage survival and improves wound healing after myocardial infarction in mice, Circ Res., 124, 1323, 10.1161/CIRCRESAHA.118.314569 · DOI
  18. Meyer, 2012, Platelet TGF-β 1 contributions to plasma TGF-β 1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload, Blood., 119, 1064, 10.1182/blood-2011-09-377648 · DOI · Paper page
  19. Saxena, 2014, Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function, Am J Physiol Heart Circ Physiol., 307, H1233, 10.1152/ajpheart.00328.2014 · DOI · Paper page
  20. Weirather, 2014, Foxp3+CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation, Circ Res., 115, 55, 10.1161/CIRCRESAHA.115.303895 · DOI · Paper page
  21. Frangogiannis, 1998, Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion, Circulation., 98, 687, 10.1161/01.CIR.98.7.687 · DOI · Paper page
  22. Annes, 2003, Making sense of latent TGFbeta activation, J Cell Sci., 116, 217, 10.1242/jcs.00229 · DOI · Paper page
  23. Gentry, 1990, The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor, Biochemistry., 29, 6851, 10.1021/bi00481a014 · DOI · Paper page
  24. Birdsall, 1997, Complement C5a, TGF-β 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion, Circulation., 95, 684, 10.1161/01.CIR.95.3.684 · DOI · Paper page
  25. Bujak, 2007, Essential role of smad3 in infarct healing and in the pathogenesis of cardiac remodeling, Circulation., 116, 2127, 10.1161/CIRCULATIONAHA.107.704197 · DOI · Paper page
  26. Nishimura, 2009, Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders, Am J Pathol., 175, 1362, 10.2353/ajpath.2009.090393 · DOI
  27. Sarrazy, 2014, Integrins αvβ5 and αvβ3 promote latent TGF-β 1 activation by human cardiac fibroblast contraction, Cardiovasc Res., 102, 407, 10.1093/cvr/cvu053 · DOI · Paper page
  28. Spinale, 2007, Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function, Physiol Rev., 87, 1285, 10.1152/physrev.00012.2007 · DOI · Paper page
  29. Villarreal, 2004, Early degradation and serum appearance of type I collagen fragments after myocardial infarction, J Mol Cell Cardiol., 36, 597, 10.1016/j.yjmcc.2004.01.004 · doi:10.1016/j.yjmcc.2004.01.004
  30. Liu, 2018, Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials, Nat Rev Cardiol., 15, 351, 10.1038/s41569-018-0002-3 · DOI · Paper page
  31. Frangogiannis, 2005, The critical role of endogenous Thrombospondin (TSP)-1 in preventing expansion of healing myocardial infarcts, Circulation., 111, 2935, 10.1161/CIRCULATIONAHA.104.510354 · DOI · Paper page
  32. Frangogiannis, 2012, Matricellular proteins in cardiac adaptation and disease, Physiol Rev., 92, 635, 10.1152/physrev.00008.2011 · DOI · Paper page
  33. Schellings, 2004, Matricellular proteins in the heart: possible role during stress and remodeling, Cardiovasc Res., 64, 24, 10.1016/j.cardiores.2004.06.006 · DOI · Paper page
  34. Murphy-Ullrich, 2000, Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology, Cytokine Growth Factor Rev., 11, 59, 10.1016/S1359-6101(99)00029-5 · DOI · Paper page
  35. Lefer, 1990, Mediation of cardioprotection by transforming growth factor-beta, Science., 249, 61, 10.1126/science.2164258 · DOI · Paper page
  36. Lefer, 1993, Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion, Proc Natl Acad Sci USA., 90, 1018, 10.1073/pnas.90.3.1018 · DOI
  37. Baxter, 2001, Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK, J Cardiovasc Pharmacol., 38, 930, 10.1097/00005344-200112000-00015 · DOI
  38. Schroder, 2006, Angiotensin II stimulates apoptosis via TGF-β 1 signaling in ventricular cardiomyocytes of rat, J Mol Med., 84, 975, 10.1007/s00109-006-0090-0 · DOI
  39. Wenzel, 2010, TGF-β 1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes, Basic Res Cardiol., 105, 621, 10.1007/s00395-010-0108-1 · doi:10.1007/s00395-010-0108-1
  40. Rainer, 2014, Cardiomyocyte-specific transforming growth factor beta suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after myocardial infarction, Circ Res., 114, 1246, 10.1161/CIRCRESAHA.114.302653 · DOI
  41. Travis, 2014, TGF-β activation and function in immunity, Annu Rev Immunol., 32, 51, 10.1146/annurev-immunol-032713-120257 · DOI · Paper page
  42. Fava, 1991, Transforming growth factor beta 1 (TGF-β 1) induced neutrophil recruitment to synovial tissues: implications for TGF-β -driven synovial inflammation and hyperplasia, J Exp Med., 173, 1121, 10.1084/jem.173.5.1121 · DOI · Paper page
  43. Wahl, 1987, Transforming growth factor type beta induces monocyte chemotaxis and growth factor production, Proc Natl Acad Sci USA., 84, 5788, 10.1073/pnas.84.16.5788 · DOI · Paper page
  44. Smith, 1996, Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium, J Immunol., 157, 360, 10.4049/jimmunol.157.1.360 · DOI · Paper page
  45. Letterio, 1998, Regulation of immune responses by TGF-β, Annu Rev Immunol., 16, 137, 10.1146/annurev.immunol.16.1.137 · DOI · Paper page
  46. Werner, 2000, Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3, J Biol Chem., 275, 36653, 10.1074/jbc.M004536200 · DOI · Paper page
  47. Feinberg, 2004, Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation, Circ Res., 94, 601, 10.1161/01.RES.0000119170.70818.4F · DOI
  48. Kitamura, 1996, Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells, J Immunol., 156, 2964, 10.4049/jimmunol.156.8.2964 · doi:10.4049/jimmunol.156.8.2964
  49. Gorelik, 2000, Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease, Immunity., 12, 171, 10.1016/S1074-7613(00)80170-3 · DOI · Paper page
  50. Dutta, 2015, Monocytes in myocardial infarction, Arterioscler Thromb Vasc Biol., 35, 1066, 10.1161/ATVBAHA.114.304652 · DOI · Paper page
  51. Shiraishi, 2016, Alternatively activated macrophages determine repair of the infarcted adult murine heart, J Clin Invest., 126, 2151, 10.1172/JCI85782 · DOI · Paper page
  52. Ikeuchi, 2004, Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction, Cardiovasc Res., 64, 526, 10.1016/j.cardiores.2004.07.017 · DOI · Paper page
  53. Xiao, 2006, Oxidants selectively reverse TGF-β suppression of proinflammatory mediator production, J Immunol., 176, 1209, 10.4049/jimmunol.176.2.1209 · DOI
  54. Celada, 1992, Transforming growth factor-beta enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages, J Immunol., 148, 1102, 10.4049/jimmunol.148.4.1102 · DOI
  55. Ding, 1990, Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma, J Immunol., 145, 940, 10.4049/jimmunol.145.3.940 · DOI · Paper page
  56. Nelson, 1991, Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1, J Immunol., 146, 1849, 10.4049/jimmunol.146.6.1849 · DOI
  57. Oh, 2013, TGF-β: guardian of T cell function, J Immunol., 191, 3973, 10.4049/jimmunol.1301843 · DOI · Paper page
  58. Chen, 2015, Development of thymic Foxp3(+) regulatory T cells: TGF-β matters, Eur J Immunol., 45, 958, 10.1002/eji.201444999 · DOI
  59. Wahl, 2004, TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells, J Leukoc Biol., 76, 15, 10.1189/jlb.1103539 · DOI · Paper page
  60. Hofmann, 2012, Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice, Circulation., 125, 1652, 10.1161/CIRCULATIONAHA.111.044164 · DOI · Paper page
  61. Kanisicak, 2016, Genetic lineage tracing defines myofibroblast origin and function in the injured heart, Nat Commun., 7, 12260, 10.1038/ncomms12260 · DOI · Paper page
  62. Ruiz-Villalba, 2015, Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar, J Am Coll Cardiol., 65, 2057, 10.1016/j.jacc.2015.03.520 · DOI
  63. Frangogiannis, 2000, Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb), Cardiovasc Res., 48, 89, 10.1016/S0008-6363(00)00158-9 · DOI · Paper page
  64. Shinde, 2014, Fibroblasts in myocardial infarction: a role in inflammation and repair, J Mol Cell Cardiol., 74, 10.1016/j.yjmcc.2013.11.015 · DOI · Paper page
  65. Cleutjens, 1995, Collagen remodeling after myocardial infarction in the rat heart, Am J Pathol., 147, 325
  66. Shinde, 2017, Mechanisms of fibroblast activation in the remodeling myocardium, Curr Pathobiol Rep., 5, 145, 10.1007/s40139-017-0132-z · DOI
  67. Humeres, 2019, Fibroblasts in the infarcted, remodeling, and failing heart, JACC Basic Transl Sci., 4, 449, 10.1016/j.jacbts.2019.02.006 · DOI · Paper page
  68. Shinde, 2017, The role of alpha-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling, Biochim Biophys Acta., 1863, 298, 10.1016/j.bbadis.2016.11.006 · DOI · Paper page
  69. Eghbali, 1991, Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors, Circ Res., 69, 483, 10.1161/01.RES.69.2.483 · DOI · Paper page
  70. Chua, 1991, Effect of growth factors on collagen metabolism in cultured human heart fibroblasts, Connect Tissue Res., 26, 271, 10.3109/03008209109152444 · DOI
  71. Russo, 2019, Protective effects of activated myofibroblasts in the pressure-overloaded myocardium are mediated through smad-dependent activation of a matrix-preserving program, Circ Res., 124, 1214, 10.1161/CIRCRESAHA.118.314438 · DOI
  72. Yi, 2014, Hepatocyte growth factor regulates the TGF-β 1-induced proliferation, differentiation and secretory function of cardiac fibroblasts, Int J Mol Med., 34, 381, 10.3892/ijmm.2014.1782 · DOI
  73. Frantz, 2008, Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction, Basic Res Cardiol., 103, 485, 10.1007/s00395-008-0739-7 · DOI · Paper page
  74. Okada, 2005, Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure, Circulation., 111, 2430, 10.1161/01.CIR.0000165066.71481.8E · DOI · Paper page
  75. Frangogiannis, 2007, Chemokines in ischemia and reperfusion, Thromb Haemost., 97, 738, 10.1160/TH07-01-0022 · DOI · Paper page
  76. Kumar, 1997, Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium, Circulation., 95, 693, 10.1161/01.CIR.95.3.693 · doi:10.1161/01.cir.95.3.693
  77. Frangogiannis, 2014, The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities, J Cardiovasc Pharmacol., 63, 185, 10.1097/FJC.0000000000000003 · DOI · Paper page
  78. Virag, 2003, Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair, Am J Pathol., 163, 2433, 10.1016/S0002-9440(10)63598-5 · DOI · Paper page
  79. Ren, 2002, Morphological characteristics of the microvasculature in healing myocardial infarcts, J Histochem Cytochem., 50, 71, 10.1177/002215540205000108 · DOI · Paper page
  80. Dobaczewski, 2004, Vascular mural cells in healing canine myocardial infarcts, J Histochem Cytochem., 52, 1019, 10.1369/jhc.3A6210.2004 · DOI
  81. Zymek, 2006, The role of platelet-derived growth factor signaling in healing myocardial infarcts, J Am Coll Cardiol., 48, 2315, 10.1016/j.jacc.2006.07.060 · DOI · Paper page
  82. Pepper, 1997, Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity, Cytokine Growth Factor Rev., 8, 21, 10.1016/S1359-6101(96)00048-2 · DOI · Paper page
  83. Frangogiannis, 2001, Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis, FASEB J., 15, 1428, 10.1096/fj.00-0745fje · DOI
  84. Pardali, 2009, Transforming growth factor-beta signaling and tumor angiogenesis, Front Biosci., 14, 4848, 10.2741/3573 · DOI
  85. Massague, 2012, TGF-β control of stem cell differentiation genes, FEBS Lett., 586, 1953, 10.1016/j.febslet.2012.03.023 · DOI · Paper page
  86. Chablais, 2012, The regenerative capacity of the zebrafish heart is dependent on TGFβ signaling, Development., 139, 1921, 10.1242/dev.078543 · DOI · Paper page
  87. Chen, 2015, Pharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration, Cardiovasc Res., 105, 44, 10.1093/cvr/cvu229 · DOI
  88. Behfar, 2002, Stem cell differentiation requires a paracrine pathway in the heart, Faseb J., 16, 1558, 10.1096/fj.02-0072com · DOI · Paper page
  89. Willems, 2012, Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells, Cell Stem Cell., 11, 242, 10.1016/j.stem.2012.04.025 · DOI
  90. Chen, 2012, Small molecule regulators of postnatal Nkx2.5 cardiomyoblast proliferation and differentiation, J Cell Mol Med., 16, 961, 10.1111/j.1582-4934.2011.01513.x · doi:10.1111/j.1582-4934.2011.01513.x
  91. Li, 2005, Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells, Circulation., 111, 2438, 10.1161/01.CIR.0000167553.49133.81 · DOI
  92. Wu, 2019, Bone morphogenetic protein signaling in inflammation, Exp Biol Med., 244, 147, 10.1177/1535370219828694 · DOI
  93. Mueller, 2012, Promiscuity and specificity in BMP receptor activation, FEBS Lett., 586, 1846, 10.1016/j.febslet.2012.02.043 · DOI · Paper page
  94. Morrell, 2016, Targeting BMP signalling in cardiovascular disease and anaemia, Nat Rev Cardiol., 13, 106, 10.1038/nrcardio.2015.156 · DOI · Paper page
  95. Noseda, 2011, Cardiopoietic factors: extracellular signals for cardiac lineage commitment, Circ Res., 108, 129, 10.1161/CIRCRESAHA.110.223792 · DOI
  96. Monzen, 1999, Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4, Mol Cell Biol., 19, 7096, 10.1128/MCB.19.10.7096 · DOI · Paper page
  97. Zhang, 1996, Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development, Development., 122, 2977, 10.1242/dev.122.10.2977 · DOI · Paper page
  98. Ghosh-Choudhury, 2003, BMP-2 regulates cardiomyocyte contractility in a phosphatidylinositol 3 kinase-dependent manner, FEBS Lett., 544, 181, 10.1016/S0014-5793(03)00507-6 · DOI
  99. Sanders, 2016, BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction, Circ Res., 119, 434, 10.1161/CIRCRESAHA.116.308700 · DOI
  100. Rutkovskiy, 2017, Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humans, Scand J Clin Lab Invest., 77, 321, 10.1080/00365513.2017.1318447 · DOI
  101. Chang, 2008, Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation, Stem Cells., 26, 1901, 10.1634/stemcells.2007-0708 · DOI
  102. Izumi, 2001, Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway, J Biol Chem., 276, 31133, 10.1074/jbc.M101463200 · DOI
  103. Ebelt, 2013, Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice, Shock., 39, 353, 10.1097/SHK.0b013e318289728a · DOI
  104. Yang, 2009, Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors, Endocrinology., 150, 727, 10.1210/en.2008-0090 · DOI
  105. Benn, 2017, Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence, FASEB J., 31, 4720, 10.1096/fj.201700193RR · DOI
  106. Cagavi, 2014, Functional cardiomyocytes derived from Isl1 cardiac progenitors via Bmp4 stimulation, PLoS ONE., 9, e110752, 10.1371/journal.pone.0110752 · DOI
  107. Takei, 2009, Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development, Am J Physiol Heart Circ Physiol., 296, H1793, 10.1152/ajpheart.01288.2008 · DOI
  108. Wu, 2014, Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart, Life Sci., 97, 145, 10.1016/j.lfs.2013.12.030 · DOI
  109. Lu, 2014, Bone morphogenetic protein-2 antagonizes bone morphogenetic protein-4 induced cardiomyocyte hypertrophy and apoptosis, J Cell Physiol., 229, 1503, 10.1002/jcp.24592 · DOI
  110. Pachori, 2010, Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway, J Mol Cell Cardiol., 48, 1255, 10.1016/j.yjmcc.2010.01.010 · DOI
  111. Sun, 2013, Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy, Hypertension., 61, 352, 10.1161/HYPERTENSIONAHA.111.00562 · DOI
  112. Li, 2014, Bone morphogenetic protein 4 inhibits liposaccharide-induced inflammation in the airway, Eur J Immunol., 44, 3283, 10.1002/eji.201344287 · DOI
  113. Helbing, 2017, Endothelial BMP4 regulates leukocyte diapedesis and promotes inflammation, Inflammation., 40, 1862, 10.1007/s10753-017-0627-0 · DOI
  114. Heinke, 2008, BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis, Circ Res., 103, 804, 10.1161/CIRCRESAHA.108.178434 · DOI · Paper page
  115. Meynard, 2009, Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat Genet., 41, 478, 10.1038/ng.320 · DOI · Paper page
  116. Kim, 2001, Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart, Dev Biol., 235, 449, 10.1006/dbio.2001.0284 · DOI · Paper page
  117. Banach, 2016, Bone morphogenetic protein 6-a possible new player in pathophysiology of heart failure, Clin Exp Pharmacol Physiol., 43, 1247, 10.1111/1440-1681.12665 · DOI
  118. Helder, 1995, Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development, J Histochem Cytochem., 43, 1035, 10.1177/43.10.7560881 · doi:10.1177/43.10.7560881
  119. Dudley, 1997, Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos, Dev Dyn., 208, 349, 10.1002/(SICI)1097-0177(199703)208:3<349::AID-AJA6>3.0.CO;2-I · DOI · Paper page
  120. Merino, 2016, BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery, Cardiovasc Res., 110, 331, 10.1093/cvr/cvw076 · DOI
  121. Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat Med., 13, 952, 10.1038/nm1613 · DOI · Paper page
  122. Urbina, 2014, BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy, Am J Physiol Heart Circ Physiol., 307, H762, 10.1152/ajpheart.00367.2014 · DOI
  123. Jin, 2018, Exogenous BMP-7 facilitates the recovery of cardiac function after acute myocardial infarction through counteracting TGF-β 1 signaling pathway, Tohoku J Exp Med., 244, 1, 10.1620/tjem.244.1 · DOI
  124. Huang, 2012, Myocardin regulates BMP10 expression and is required for heart development, J Clin Invest., 122, 3678, 10.1172/JCI63635 · DOI
  125. Chen, 2004, BMP10 is essential for maintaining cardiac growth during murine cardiogenesis, Development., 131, 2219, 10.1242/dev.01094 · DOI · Paper page
  126. Susan-Resiga, 2011, Furin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10, J Biol Chem., 286, 22785, 10.1074/jbc.M111.233577 · DOI
  127. Mitrofan, 2017, Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-alpha-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2, J Biol Chem., 292, 13714, 10.1074/jbc.M117.778506 · DOI
  128. Nakano, 2007, Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy, Am J Physiol Heart Circ Physiol., 293, H3396, 10.1152/ajpheart.00311.2007 · DOI
  129. Sun, 2014, Bone morphogenetic protein-10 induces cardiomyocyte proliferation and improves cardiac function after myocardial infarction, J Cell Biochem., 115, 1868, 10.1002/jcb.24856 · DOI
  130. Biesemann, 2014, Myostatin regulates energy homeostasis in the heart and prevents heart failure, Circ Res., 115, 296, 10.1161/CIRCRESAHA.115.304185 · DOI
  131. Sharma, 1999, Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct, J Cell Physiol., 180, 1, 10.1002/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.3.CO;2-M · DOI
  132. Castillero, 2015, Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy, Biochem Biophys Res Commun., 457, 106, 10.1016/j.bbrc.2014.12.057 · DOI
  133. Lim, 2018, Absence of myostatin improves cardiac function following myocardial infarction, Heart Lung Circ., 27, 693, 10.1016/j.hlc.2017.05.138 · DOI
  134. Li, 2008, Myostatin directly regulates skeletal muscle fibrosis, J Biol Chem., 283, 19371, 10.1074/jbc.M802585200 · DOI · Paper page
  135. Biesemann, 2015, Myostatin induces interstitial fibrosis in the heart via TAK1 and p38, Cell Tissue Res., 361, 779, 10.1007/s00441-015-2139-2 · DOI
  136. Artaza, 2008, Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts, J Endocrinol., 196, 235, 10.1677/JOE-07-0408 · DOI
  137. Walker, 2016, Biochemistry and biology of GDF11 and myostatin: similarities, differences, and questions for future investigation, Circ Res., 118, 1125, 10.1161/CIRCRESAHA.116.308391 · DOI · Paper page
  138. Smith, 2015, GDF11 does not rescue aging-related pathological hypertrophy, Circ Res., 117, 926, 10.1161/CIRCRESAHA.115.307527 · DOI · Paper page
  139. Harper, 2018, GDF11 decreases pressure overload-induced hypertrophy, but can cause severe cachexia and premature death, Circ Res., 123, 1220, 10.1161/CIRCRESAHA.118.312955 · DOI
  140. Du, 2017, Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury, Basic Res Cardiol., 112, 7, 10.1007/s00395-016-0593-y · DOI
  141. Su, 2019, Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury, Basic Res Cardiol., 114, 20, 10.1007/s00395-019-0728-z · DOI
  142. Luan, 2019, GDF15 is an inflammation-induced central mediator of tissue tolerance, Cell., 178, 1231, 10.1016/j.cell.2019.07.033 · DOI · Paper page
  143. Wang, 2017, GDF15 is a heart-derived hormone that regulates body growth, EMBO Mol Med., 9, 1150, 10.15252/emmm.201707604 · DOI
  144. Kempf, 2007, Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction, Eur Heart J., 28, 2858, 10.1093/eurheartj/ehm465 · DOI · Paper page
  145. Wollert, 2007, Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome, Circulation., 116, 1540, 10.1161/CIRCULATIONAHA.107.697714 · DOI · Paper page
  146. Wollert, 2007, Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome, Circulation., 115, 962, 10.1161/CIRCULATIONAHA.106.650846 · DOI · Paper page
  147. Bloise, 2019, Activin A in mammalian physiology, Physiol Rev., 99, 739, 10.1152/physrev.00002.2018 · DOI · Paper page
  148. Walton, 2012, New insights into the mechanisms of activin action and inhibition, Mol Cell Endocrinol., 359, 2, 10.1016/j.mce.2011.06.030 · DOI
  149. Yndestad, 2004, Elevated levels of activin A in heart failure: potential role in myocardial remodeling, Circulation., 109, 1379, 10.1161/01.CIR.0000120704.97934.41 · DOI · Paper page
  150. Chen, 2014, Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury, Cytokine., 69, 255, 10.1016/j.cyto.2014.06.017 · DOI
  151. Oshima, 2009, Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury, Circulation., 120, 1606, 10.1161/CIRCULATIONAHA.109.872200 · DOI
  152. Hu, 2016, Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1/2 and p38-MAPK pathways, Eur J Pharmacol., 789, 319, 10.1016/j.ejphar.2016.07.053 · DOI
  153. Hu, 2018, Activin A inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats, Mol Med Rep., 17, 5074, 10.3892/mmr.2018.8496 · doi:10.3892/mmr.2018.8496
  154. Shimano, 2011, Cardiac myocyte-specific ablation of follistatin-like 3 attenuates stress-induced myocardial hypertrophy, J Biol Chem., 286, 9840, 10.1074/jbc.M110.197079 · DOI
  155. Panse, 2012, Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes, J Cardiovasc Transl Res., 5, 814, 10.1007/s12265-012-9400-9 · DOI
  156. Massague, 2000, How cells read TGF-β signals, Nat Rev Mol Cell Biol., 1, 169, 10.1038/35043051 · DOI · Paper page
  157. Rahimi, 2007, TGF-β signaling: a tale of two responses, J Cell Biochem., 102, 593, 10.1002/jcb.21501 · DOI · Paper page
  158. Goumans, 2002, Balancing the activation state of the endothelium via two distinct TGF-β type I receptors, Embo J., 21, 1743, 10.1093/emboj/21.7.1743 · DOI · Paper page
  159. Funaba, 2002, Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase, J Biol Chem., 277, 41361, 10.1074/jbc.M204597200 · DOI · Paper page
  160. Kretzschmar, 1999, A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras, Genes Dev., 13, 804, 10.1101/gad.13.7.804 · DOI · Paper page
  161. Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-β family signalling, Nature., 425, 577, 10.1038/nature02006 · DOI · Paper page
  162. Kong, 2018, Opposing actions of fibroblast and cardiomyocyte Smad3 signaling in the infarcted myocardium, Circulation., 137, 707, 10.1161/CIRCULATIONAHA.117.029622 · DOI · Paper page
  163. Chen, 2019, Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation, Circ Res., 125, 55, 10.1161/CIRCRESAHA.119.315069 · DOI · Paper page
  164. Huang, 2019, Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart, J Mol Cell Cardiol., 132, 84, 10.1016/j.yjmcc.2019.05.006 · DOI
  165. Tan, 2010, Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction, Am J Physiol Heart Circ Physiol., 298, H1415, 10.1152/ajpheart.01048.2009 · DOI
  166. Masaki, 2005, Smad1 protects cardiomyocytes from ischemia-reperfusion injury, Circulation., 111, 2752, 10.1161/CIRCULATIONAHA.104.490946 · DOI
  167. Kumagai, 2016, Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction, Cardiovasc Res., 109, 272, 10.1093/cvr/cvv273 · DOI
  168. Engel, 1999, Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription, J Biol Chem., 274, 37413, 10.1074/jbc.274.52.37413 · DOI · Paper page
  169. Yu, 2002, TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses, Embo J., 21, 3749, 10.1093/emboj/cdf366 · DOI · Paper page
  170. Matsumoto-Ida, 2006, Activation of TGF-β 1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats, Am J Physiol Heart Circ Physiol., 290, H709, 10.1152/ajpheart.00186.2005 · DOI
  171. Molkentin, 2017, Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis, Circulation., 136, 549, 10.1161/CIRCULATIONAHA.116.026238 · DOI · Paper page
  172. Bageghni, 2018, Cardiac fibroblast-specific p38alpha MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism, FASEB J., 32, 4941, 10.1096/fj.201701455RR · DOI
  173. Leask, 2010, Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation, Circ Res., 106, 1675, 10.1161/CIRCRESAHA.110.217737 · DOI · Paper page
  174. Frangogiannis, 2014, The inflammatory response in myocardial injury, repair, and remodelling, Nat Rev Cardiol., 11, 255, 10.1038/nrcardio.2014.28 · DOI · Paper page
  175. Frangogiannis, 2014, Targeting the transforming growth factor (TGF)-β cascade in the remodeling heart: benefits and perils, J Mol Cell Cardiol., 76, 169, 10.1016/j.yjmcc.2014.09.001 · DOI
  176. Tan, 2013, SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS, J Am Heart Assoc., 2, e000269, 10.1161/JAHA.113.000269 · DOI
  177. Biernacka, 2015, Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice, Circ Heart Fail., 8, 788, 10.1161/CIRCHEARTFAILURE.114.001963 · DOI
  178. Regalado, 2011, Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms, Circ Res., 109, 680, 10.1161/CIRCRESAHA.111.248161 · DOI · Paper page

Cited by

See all 251

Metadata

Authors
Hanna, A., & Frangogiannis, N. G.
Venue
Frontiers in Cardiovascular Medicine
Published
2019-09-18
Volume
6
Pages
140-140
ISSN
2297-055X (ISSN-L)
OpenAlex
W2971555794
Cited by
251
References
17
FWCI
21.35
Type
journal article
Language
en
Open access
gold
Funders
  • National Heart, Lung, and Blood Institute (R01 HL76246)
  • U.S. Department of Defense (PR151134)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of the TGF-β Superfamily in Myocardial Infarction. https://app.cochat.ai/papers/10.3389/fcvm.2019.00140
The paper
Hanna, A., & Frangogiannis, N. G. (2019). The Role of the TGF-β Superfamily in Myocardial Infarction. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2019.00140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.